These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30317360)

  • 21. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital.
    Otieno FC; Ng'ang'a L; Kariuki M
    East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.
    Karl D; Zhou R; Vlajnic A; Riddle M
    Diabet Med; 2012 Jul; 29(7):933-6. PubMed ID: 22413808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, 1-year comparison of three ways to initiate and advance insulin for type 2 diabetes: twice-daily premixed insulin versus basal insulin with either basal-plus one prandial insulin or basal-bolus up to three prandial injections.
    Riddle MC; Rosenstock J; Vlajnic A; Gao L
    Diabetes Obes Metab; 2014 May; 16(5):396-402. PubMed ID: 24118931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensive glycaemic control in type 2 diabetes mellitus: does it improve cardiovascular outcomes?
    Reddy SV; Bhatia E
    Natl Med J India; 2011; 24(1):21-7. PubMed ID: 21608354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.
    Giugliano D; Ceriello A; Razzoli E; Esposito K
    Clin Drug Investig; 2008; 28(4):199-210. PubMed ID: 18345710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superior glycaemic control with once-daily insulin degludec/insulin aspart versus insulin glargine in Japanese adults with type 2 diabetes inadequately controlled with oral drugs: a randomized, controlled phase 3 trial.
    Onishi Y; Ono Y; Rabøl R; Endahl L; Nakamura S
    Diabetes Obes Metab; 2013 Sep; 15(9):826-32. PubMed ID: 23557077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycaemic treatment of newly diagnosed type 2 diabetes.
    Davidson MB
    Diabetes Obes Metab; 2024 Nov; 26(11):5492-5493. PubMed ID: 39205647
    [No Abstract]   [Full Text] [Related]  

  • 28. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycosylated haemoglobin: its correlation with blood sugar in management of maturity onset diabetes mellitus.
    Juneja SC; Ohri VC; Bhalla IP; Singh B; Sindhi JC; Rastogi DS
    J Assoc Physicians India; 1984 Sep; 32(9):785-8. PubMed ID: 6511766
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of insulin analogues in pregnancy.
    Lambert K; Holt RI
    Diabetes Obes Metab; 2013 Oct; 15(10):888-900. PubMed ID: 23489521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data from PREDICTIVE.
    Dornhorst A; Lüddeke HJ; Koenen C; Meriläinen M; King A; Robinson A; Sreenan S;
    Diabetes Obes Metab; 2008 Jan; 10(1):75-81. PubMed ID: 18034846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline HbA1c predicts attainment of 7.0% HbA1c target with structured titration of insulin glargine in type 2 diabetes: a patient-level analysis of 12 studies.
    Riddle MC; Vlajnic A; Zhou R; Rosenstock J
    Diabetes Obes Metab; 2013 Sep; 15(9):819-25. PubMed ID: 23489438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents.
    Jacober SJ; Scism-Bacon JL; Zagar AJ
    Diabetes Obes Metab; 2006 Jul; 8(4):448-55. PubMed ID: 16776752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nateglinide improves glycaemic control when added to metformin monotherapy: results of a randomized trial with type 2 diabetes patients.
    Marre M; Van Gaal L; Usadel KH; Ball M; Whatmough I; Guitard C
    Diabetes Obes Metab; 2002 May; 4(3):177-86. PubMed ID: 12047396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-titration of biphasic insulin aspart 30/70 improves glycaemic control and allows easy intensification in a Dutch clinical practice.
    Ligthelm RJ
    Prim Care Diabetes; 2009 May; 3(2):97-102. PubMed ID: 19285933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strong correlation between glycaemic variability and total glucose exposure in type 2 diabetes is limited to subjects with satisfactory glycaemic control.
    Suh S; Joung JY; Jin SM; Kim MY; Bae JC; Park HD; Lee MS; Lee MK; Kim JH
    Diabetes Metab; 2014 Sep; 40(4):272-7. PubMed ID: 24630733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of preprandial vs. postprandial insulin glulisine on weight and glycaemic control in patients initiating basal-bolus regimen for type 2 diabetes: a multicenter, randomized, parallel, open-label study (NCT00135096).
    Ratner R; Wynne A; Nakhle S; Brusco O; Vlajnic A; Rendell M
    Diabetes Obes Metab; 2011 Dec; 13(12):1142-8. PubMed ID: 21812890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colesevelam for type 2 diabetes mellitus.
    Ooi CP; Loke SC
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD009361. PubMed ID: 23235674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of red cell distribution width, glycaemic control and diabetes related complications - the ARDENT Study.
    Arif MA; Syed F; Niazi R; Arif SA; Javed MU; Bashir A; Mansoor S
    J Pak Med Assoc; 2019 Apr; 69(4):483-488. PubMed ID: 31000849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between HbA1c and hypoglycaemia in patients with type 2 diabetes treated with different insulin regimens in combination with metformin.
    Chan JY; Leyk M; Frier BM; Tan MH
    Diabetes Metab Res Rev; 2009 Mar; 25(3):224-31. PubMed ID: 19156705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.